Search

everythinglearnresearchcommunity

for

Search:↓

Human hair color is determined by melanin types and genetic factors.

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

Modern hair restoration techniques have evolved from punch grafting to methods like micro-grafting and follicular unit transplantation, but they are labor-intensive, expensive, and can lead to patient dissatisfaction. Future treatments may involve cloned hair follicles and drugs like finasteride.

The model predicts minoxidil's effectiveness and side effects better than traditional methods.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Bio-enhanced hair restoration, using methods like growth factors, stem cells, and ATP, results in better hair growth and density than traditional hair transplants.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Hair transplantation techniques have improved over 12 years, with follicular unit grafting providing more natural results and potential future advances in automation and genetics.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Honeybees face serious threats from various diseases, but beekeepers use several methods to manage and control them.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

The document lists various dermatology topics, treatments, and diagnostic methods.

More research is needed on better diagnostics, survivorship, and the impact of genetic mutations in lung cancer.

The document recommends several books on cosmetic surgery and complementary medicine, highlighting their detailed methods, multidisciplinary approaches, and valuable treatment insights.

Scalp micropigmentation usually needs two to three sessions, but factors like genetics, coverage area, and health conditions can require more.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

A combined approach is needed to fully understand adult stem cells, with genetic lineage-tracing being crucial.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

New imaging technologies help us see how stem cells work in living animals.

Genomic research can help improve the quality and production of natural fibers in animals.

These gene variations are not linked to alopecia areata in Egyptians.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.